Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.
about
Hematopoietic stem cell transplantation for people with ß-thalassaemia majorPolyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adultsHematopoietic stem cell transplantation for people with ß-thalassaemia majorHLA-matched sibling bone marrow transplantation for β-thalassemia majorHematopoietic stem cell transplantation for people with ß-thalassaemia major.Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell graftsTreosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients.Stem cell transplantation in India.Busulfan in hematopoietic stem cell transplant setting.Umbilical cord blood transplantation for non-malignant diseases.Conditioning regimens in allo-SCT for thalassemia major.Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation.Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation.
P2860
Q24193101-F690BCBD-5E46-4C8C-AB6B-349D99327DACQ24200813-2CB930CA-319C-4626-91A8-132DBEBAC6CBQ24236027-D407D622-AAF6-4CD9-B9B0-C53CF769A26EQ24600037-AA8FE13E-FA3C-4BF9-9D09-3F18CE533CB3Q34546216-15EF1409-A497-4058-BB09-30E688846CE8Q34700498-045E1E28-9826-4292-BDFB-519661A29658Q35073850-AD353972-878B-407D-9C70-AE8CA0F724A4Q35924098-A6857975-83C1-4AE8-B08C-CE3AE38EDFBBQ36792760-E69E50B5-71E9-448A-93E1-3A54D068E0ABQ37251065-4BF62B86-7733-4405-BA76-53B14F72CC6CQ37554387-FF5DE5B4-5C4A-4059-9E10-6EC333117E0FQ37607972-7AA05222-07EA-4DA8-9984-2564B8CA74D9Q38179977-E185F17F-6F15-4BC5-BD8D-671A12F47FF8Q50073298-D5CB9C2A-C17D-41A3-A3D8-00FABD3E784CQ50105348-154626EE-2301-4579-9F7A-729EC695D86EQ51020500-CB49036E-3F9C-449C-ABD4-F64160DA5187Q54918960-B13FD22E-AE4E-4594-B035-5DBD3D4B4507
P2860
Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Randomized trial of two differ ...... netics in determining outcome.
@en
Randomized trial of two differ ...... netics in determining outcome.
@nl
type
label
Randomized trial of two differ ...... netics in determining outcome.
@en
Randomized trial of two differ ...... netics in determining outcome.
@nl
prefLabel
Randomized trial of two differ ...... netics in determining outcome.
@en
Randomized trial of two differ ...... netics in determining outcome.
@nl
P2093
P2860
P356
P1476
Randomized trial of two differ ...... netics in determining outcome.
@en
P2093
Balasubramanian P
Dennison D
Krishnamoorthy R
Ramachandran SV
Srivastava A
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705151
P407
P577
2005-11-01T00:00:00Z